Are there FDA‑approved, evidence‑based supplements that can help lower high blood pressure?

FDA-Approved Supplements for Blood Pressure Reduction

There are no FDA-approved supplements specifically indicated for lowering blood pressure, but evidence-based dietary approaches using potassium-rich foods (not supplements) are strongly recommended by international guidelines, while certain supplements like CoQ10 (100-200 mg/d) and magnesium show modest blood pressure reductions in specific populations.

Guideline-Based Recommendations: Dietary Potassium vs. Supplements

The Critical Distinction

International hypertension guidelines from 2018-2024 consistently emphasize a crucial point: increase dietary potassium through food sources, but do not use potassium supplements for blood pressure reduction 1.

• UK NICE Guidelines (2019): Explicitly state "Do not offer calcium, magnesium, or potassium supplements as a method for reducing BP" 1
• Chinese Guidelines (2018): "It is not recommended to take potassium supplements (including drugs) to reduce BP" 1
• Saudi Guidelines (2018): "Pharmacological potassium supplementation is not recommended. A natural source of potassium is preferable" 1

What IS Recommended

Guidelines universally support:

• Fresh fruits and vegetables (4-5 servings/day, 300-400 g/day)
• Target potassium intake: ≥3000 mg/day from food sources
• Potassium-enriched salt substitutes (for those with normal kidney function)
• Contraindication: Avoid in renal insufficiency or hyperkalemia risk 1

Evidence-Based Supplements with Blood Pressure Effects

Coenzyme Q10: Strongest Evidence for Supplementation

CoQ10 at 100-200 mg/day shows the most consistent blood pressure reduction in patients with cardiometabolic diseases 2.

Key findings:

• Systolic BP reduction: -4.77 mmHg (95% CI: -6.57, -2.97)
• U-shaped dose-response curve with optimal benefit at 100-200 mg/day
• Greater effects in patients with diabetes and dyslipidemia
• Requires >12 weeks duration for maximal benefit
• Quality of evidence: Moderate (GRADE assessment) 2

Clinical application: This is the supplement with the strongest evidence for actual blood pressure reduction, particularly in patients with existing cardiometabolic conditions.

Magnesium and Calcium: Modest Reductions

In normotensive populations, mineral supplementation shows small but significant effects 3:

• Magnesium: -2.79/-1.56 mmHg (SBP/DBP)
• Calcium: -1.37/-1.63 mmHg (SBP/DBP)
• Potassium supplements: -2.10 mmHg SBP only (contradicts guideline recommendations)

Important caveat: These studies were in normotensive populations, and guidelines explicitly recommend against mineral supplements for hypertension management 1.

Other Supplements with Limited Evidence

Omega-3 fatty acids (EPA/DHA):

• Slight systolic and diastolic reductions in hypertensive or high-risk individuals
• Effects mediated through endothelial function and inflammation
• Heterogeneous study results limit definitive recommendations 4

Flaxseed:

• SBP reduction: -4.30 mmHg; DBP: -2.50 mmHg
• More effective with whole flaxseed, 10-20 week duration, BMI 25-30 kg/m²
• Best results in hypertensive patients 5

Riboflavin:

• Very uncertain evidence (very low-certainty, GRADE)
• Cannot recommend based on current data 6

NMN (Nicotinamide Mononucleotide):

• DBP reduction: -2.15 mmHg
• SBP reduction only in adults ≥60 years: -3.94 mmHg
• Preliminary evidence requiring confirmation 7

Clinical Algorithm for Supplement Use

First-Line Approach (Guideline-Supported):

1. Dietary potassium increase through fruits, vegetables, nuts, legumes
2. Sodium reduction to <5-6 g/day
3. Screen for renal function before any potassium-rich interventions

Second-Line Consideration (Evidence-Based but Not Guideline-Endorsed):

If patient has cardiometabolic disease and desires supplementation:

• CoQ10 100-200 mg/day for ≥12 weeks (strongest supplement evidence)
• Monitor for GI side effects

If patient is normotensive seeking prevention:

• Magnesium or calcium supplementation may provide modest benefit
• Effects are small (-1 to -3 mmHg)

Avoid:

• Isolated potassium, calcium, or magnesium supplements as primary BP treatment (contradicts guidelines) 1
• Riboflavin (insufficient evidence) 6
• Multivitamins marketed for BP (no specific evidence)

Critical Pitfalls

1. Renal function screening is mandatory before any potassium-enhancing strategy—supplements or dietary
2. Patients on potassium-sparing diuretics must limit potassium to avoid severe hyperkalemia 1
3. FDA does not approve supplements for disease treatment—these are dietary supplements, not medications
4. Magnitude of effect is modest—supplements should complement, not replace, lifestyle modifications and medications when indicated
5. Guidelines explicitly recommend against mineral supplements despite research showing small effects—this reflects the preference for dietary sources and concern about adverse effects 1